Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from China NT Pharma Group Co., Ltd. ( (HK:1011) ).
China NT Pharma Group Co., Ltd. is transforming into an AI-driven high-tech medical enterprise, focusing on building a full-cycle intelligent healthcare ecosystem for bone health. The company is advancing its bone health diagnostics business through acquisitions and partnerships, including a collaboration with a Chinese state-owned company to establish a Smart Healthcare Center, aiming to enhance shareholder returns.
More about China NT Pharma Group Co., Ltd.
China NT Pharma Group Co., Ltd. is a comprehensive pharmaceutical enterprise with 30 years of experience in the healthcare sector, known for its extensive management expertise and robust medical network. The company is transitioning into an AI-driven high-tech medical enterprise, focusing on creating an intelligent healthcare ecosystem platform, particularly in bone health.
Average Trading Volume: 921,497
Technical Sentiment Signal: Buy
Current Market Cap: HK$445M
For a thorough assessment of 1011 stock, go to TipRanks’ Stock Analysis page.